These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31951893)

  • 21. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer.
    Lee SJ; Zea R; Kim DH; Lubner MG; Deming DA; Pickhardt PJ
    Eur Radiol; 2018 Apr; 28(4):1520-1528. PubMed ID: 29164382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
    Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
    Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
    Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
    Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of computed tomography imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors.
    Utsumi M; Umeda Y; Takagi K; Takashi K; Nobuoka D; Yoshida R; Shinoura S; Sadamori H; Yagi T; Fujiwara T
    Hepatogastroenterology; 2015; 62(138):441-6. PubMed ID: 25916078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
    van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
    Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular Carcinoma: Texture Analysis of Preoperative Computed Tomography Images Can Provide Markers of Tumor Grade and Disease-Free Survival.
    Oh J; Lee JM; Park J; Joo I; Yoon JH; Lee DH; Ganeshan B; Han JK
    Korean J Radiol; 2019 Apr; 20(4):569-579. PubMed ID: 30887739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and CT Quantitative Features for Predicting Liver Metastases in Patients with Pancreatic Neuroendocrine Tumors: A Study with Prospective/External Validation.
    Pan Y; Chen HY; Chen JY; Wang XJ; Zhou JP; Shi L; Yu RS
    Acad Radiol; 2024 Sep; 31(9):3612-3619. PubMed ID: 38490841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
    Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
    Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features.
    Hu Y; Rao S; Xu X; Tang Y; Zeng M
    Abdom Radiol (NY); 2018 Nov; 43(11):3016-3024. PubMed ID: 29619528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors.
    Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X
    Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
    Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Contrast-Enhanced CT and [
    Wagner F; Hakami YA; Warnock G; Fischer G; Huellner MW; Veit-Haibach P
    Mol Imaging Biol; 2017 Oct; 19(5):795-803. PubMed ID: 28224325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors.
    Tomimaru Y; Eguchi H; Tatsumi M; Kim T; Hama N; Wada H; Kawamoto K; Kobayashi S; Morii E; Mori M; Doki Y; Nagano H
    Surgery; 2015 Feb; 157(2):269-76. PubMed ID: 25311263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
    Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
    Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma: CT texture analysis as a predictor of survival after surgical resection.
    Brenet Defour L; Mulé S; Tenenhaus A; Piardi T; Sommacale D; Hoeffel C; Thiéfin G
    Eur Radiol; 2019 Mar; 29(3):1231-1239. PubMed ID: 30159621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.